I did find out how Synergy was "affiliated" with Boehringer, by the way. I found it on "something we call the world wide web."
First, I emailed Boehringer-Ingelheim, asking about their relationship with Synergy. After a few days, here was the response:
Greetings from Boehringer-Ingelheim India..!
This has reference to the query that you have posted on Boehringer corporate ID. I wish to confirm that ‘M/s Synergy Overseas Private Ltd – Nepal (Kathmandu)’ is our authorised distributor for Nepal market. They are primarily responsible for import, promotion and distribution of selected BI products in Nepal.
I had to create a free account to view the data, but it was worth it.
The Bill of Lading Data shows that Synergy ordered 15 items from Boehringer-Ingelheim (14 in 2022, one in 2021), and the 15 orders add up to about $5000 USD.
That's right: Synergy Overseas bought $5000 worth of products from Boehringer-Ingelheim in 2021-2022.
Boehringer is Synergy's 3rd largest supplier at 9.6%. Abbott is even a smaller percentage of their business at 2.01%, Mylan is even smaller at 1.22%
Synergy's #1 supplier: Sun Pharma at 56.66% -- but the last order was 2018. Synergy's #2 supplier: Micro Labs, last order in 2019.
There's the "Evidence." Keep this in mind when someone says Boehringer-Ingelheim and Abbott and Mylan are multi-billion-dollar companies. Yeah, but... Synergy isn't.
And now Synergy looks like an abandoned car parked on a side street of the world wide web. Try it! it works.